Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Wave Life Sciences Ltd. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
WVE
Nasdaq
2830
wavelifesciences.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Wave Life Sciences Ltd.
Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial
- Dec 14th, 2025 12:40 pm
Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss
- Dec 11th, 2025 2:28 pm
WVE Stock Surges More Than 180% in a Week: What Is Driving This Rally?
- Dec 11th, 2025 8:15 am
Golden Cross Alert: 3 Stocks With Major Upside Potential
- Dec 10th, 2025 3:27 pm
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
- Dec 9th, 2025 7:50 pm
Why Wave Life Sciences Stock Crushed it Again Today
- Dec 9th, 2025 5:39 pm
Wave Life Sciences (WVE) Soars to 6-Year High on Obesity Drug Clinical Trial
- Dec 9th, 2025 12:24 pm
Why Wave Life Sciences (WVE) Is Up 164.9% After Obesity RNA Data And $250 Million Raise
- Dec 9th, 2025 10:09 am
Trending tickers: Nvidia, Wave Life, Toll Brothers, British American Tobacco and Moonpig
- Dec 9th, 2025 3:04 am
Why Wave Life Sciences Stock Vaulted 146% Higher on Monday
- Dec 8th, 2025 4:50 pm
Wave Life Sciences Ltd. (WVE): A Bull Case Theory
- Dec 8th, 2025 2:51 pm
Wave Life Sciences Just Targeted Fat Loss, Specifically. Shares Skyrocketed 147%.
- Dec 8th, 2025 2:09 pm
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
- Dec 8th, 2025 2:01 pm
Wave Life skyrockets on obesity drug trial, Strategy buys bitcoin
- Dec 8th, 2025 1:44 pm
Top Midday Gainers
- Dec 8th, 2025 12:33 pm
Wave Life Sciences (WVE): Assessing Valuation After Recent Share Price Weakness and Long-Term Gains
- Dec 8th, 2025 12:08 pm
Sector Update: Health Care Stocks Lower in Afternoon Trading
- Dec 8th, 2025 11:43 am
Obesity Biotechs’ Gains Hit Shares of Eli Lilly, Novo Nordisk
- Dec 8th, 2025 10:46 am
BC-Most Active Stocks
- Dec 8th, 2025 8:30 am
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
- Dec 8th, 2025 5:30 am
Scroll